Cargando…

COVID-19 vaccine type and Guillain-Barré syndrome: Comment

Detalles Bibliográficos
Autores principales:	Kleebayoon, Amnuay, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Coronavirus
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294747/ https://www.ncbi.nlm.nih.gov/pubmed/37096296 http://dx.doi.org/10.1080/21645515.2023.2200355

Ejemplares similares

Willingness of college students to receive COVID-19 heterologous vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Intention to receive COVID-19 vaccine and its health belief model (HBM)-based predictors: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Heterologous COVID-19 vaccination in pregnant women: Comment
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review
por: Lee, Hsin-Yu, et al.
Publicado: (2023)

COVID-19 vaccines and retinal microvasculature: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on Determinants of the Attitude to COVID-19 Vaccine
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccine-associated autoimmune disorders: Comments
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccination uptake in people with epilepsy: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute disseminated encephalomyelitis and COVID-19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Assessment of psychological distress & COVID-19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute myocarditis after administration of COVID-19 vaccine: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccination and idiopathic sudden sensorineural hearing loss: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on immunity to COVID-19 vaccination in patients with liver disease and transplant recipients
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Factors affecting intention of COVID‐19 preventive behaviours including vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: Comment
por: Mungmunpuntipantip, Rujitika, et al.
Publicado: (2023)

Heterologous mRNA-based COVID-19 booster strategies: Comment
por: Yasri, Sora, et al.
Publicado: (2023)

Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

“Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents: A pediatric case report”: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment: Post COVID-19 Vaccination Encephalitis as a Cause of Subacute Progressive Dementia: A Case Report and Literature Review
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Post COVID-19 vaccination Guillain-Barre syndrome: three cases
por: Tabatabaee, Seyedehnarges, et al.
Publicado: (2022)

Comment on the effectiveness of four SARS-COV-2 vaccines
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

SARS-CoV-2 vaccination for unexpected death from atrial myocarditis: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Self-reported side effects following COVID-19 vaccination in athletes: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Vaccination rates, perceptions, and information sources in inflammatory arthritis: Comment on the article by Lyon et al
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on outcomes following COVID-19 vaccination and associated factors among healthcare professionals
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Ocular sparganosis: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on adverse conditions of COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccines and increased blood pressure
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Hesitancy toward vaccination against COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 infection and vaccination among children
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Post-Vaccine SARS-CoV-2 Reinfection and Associated Factors Among Health Care Providers: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Stroke after SARS-CoV-2 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute interstitial nephritis following COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Side effects of COVID-19 vaccination and breast cancer
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccination status and related process of care outcomes
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccine immune response and plasma cell dyscrasia
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vbkka43abrcph4kn2i285r0af0